Ergebnis für "Bad Blood" in Politik & Sozialwissenschaften

Elizabeth Holmes, die Gründerin von Theranos, galt lange als der weibliche Steve Jobs. Das 19-jährige Start-up-Wunderkind versprach, mit ihrer Firma die Medizinindustrie zu revolutionieren. Ein einziger Tropfen Blut sollte reichen, um Blutbilder zu erstellen und Therapien zu steuern - eine Riesenhoffnung für Millionen Menschen und ein extrem lukratives Geschäft. Namhafte Investoren steckten Unsummen in das junge Unternehmen, bis es mit neun Milliarden Dollar am Markt kapitalisiert war. Es gab nur ein einziges Problem: Die Technologie hinter den schicken Apparaturen hat nie funktioniert.

L'histoire hallucinante de la célèbre start-up Theranos dans le livre de l'année selon le Washington Post : "Bad Blood : Scandale Theranos, secrets et mensonges au cœur de la Silicon Valley". La start-up promettait une révolution dans la sphère médicale. Elizabeth Holmes, la fondatrice de Theranos, était tellement passionnée par la médecine préventive qu'elle avait laissé tomber ses études à Stanford pour créer une entreprise au service de l'humanité.

In 1984 triplet girls born three months prematurely received life-saving blood transfusions. A year later their parents learned that their donor had the AIDS virus. After years of suffering, all three sisters died. It has been discovered that six more children have received infected blood from the same Red Cross donor. Bad Blood is the story of gross mismanagement and shocking neglect within the American Red Cross.

She was once the world's youngest self-made female billionaire. Now Elizabeth Holmes, founder of the blood-testing startup Theranos, stands accused of leading a massive fraud, and lying to investors, doctors, and patients about the capabilities of her technology. If convicted, she faces up to 20 years in prison. But Elizabeth may be able to sway a jury with her charisma, highly unusual defense strategy and the fact that key evidence has gone missing. John Carreyrou broke the Theranos scandal. Now he’ll take you into the courtroom as he examines Silicon Valley’s fake it-til-you-make it ...

Firebrand ventures into the heart of the tobacco industry and the icy paradoxes of capitalism, each chapter a counterintuitive lesson on how cigarette companies, the target of anti-smoking campaigns by health authorities, pivoted and recovered after the seismic 1964 Surgeon General's Report and 200-billion-dollar debt of the 1998 Master Settlement Agreement—and are now thriving, drenched in profits from their one billion smokers worldwide.